|
|
||||||||
From the Department of Neurology, Hebrew University-Hadassah Medical School, Jerusalem, Israel.
Address correspondence and reprint requests to Dr Leker, Department of Neurology, Hadassah Medical Center, POB 12000, Jerusalem 91120, Israel.
Anticoagulants are generally contraindicated in patients with intracerebral hematoma. However, in patients with prosthetic heart valves it may be dangerous to withhold such therapy because of possible thromboembolic complications. We treated four such patients with IV heparin starting early after the hemorrhage. The hematomas receded in all patients according to the follow-up CTs, and none had thromboembolic disorders. Three patients had good outcomes, and one remained in a persistent vegetative state after an event of acute pulmonary edema.
Supported in part by the Sol Irwin Juni Endowment Fund.
Received July 7, 1997. Accepted in final form October 8, 1997.
This article has been cited by other articles:
![]() |
L. B. Goldstein Primum non nocere: Antithombotics after intracerebral hemorrhage? Neurology, January 24, 2006; 66(2): 162 - 163. [Full Text] [PDF] |
||||
![]() |
T. G. Phan, M. Koh, and E. F. M. Wijdicks Safety of Discontinuation of Anticoagulation in Patients With Intracranial Hemorrhage at High Thromboembolic Risk Arch Neurol, December 1, 2000; 57(12): 1710 - 1713. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. F. M. Wijdicks, W. I. Schievink, R. D. Brown, C. Y. Mullany, R. R. Leker, and O. Abramsky Early anticoagulation in patients with prosthetic heart valves and intracerebral hematoma Neurology, February 1, 1999; 52(3): 673 - 673. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |